Prostate cancer: evading immunity, inspiring therapy
OPEN ACCESS
Author / Creator
Date
2026-11
Publication Type
Review Article
ETH Bibliography
yes
OPEN ACCESS
Data
Rights / License
Abstract
Prostate cancer (PCa) remains one of the most prevalent and lethal cancers in men, particularly in its metastatic form. Despite therapeutic advancements, resistance to therapy often leads to a castration-resistant state with genetic and molecular alterations that promote immune evasion and disease progression. Chronic inflammation and the immunosuppressive tumor microenvironment (TME) further exacerbate immune dysfunction. The suboptimal clinical success of current immunotherapies in advanced PCa underscores the urgent need to better understand the mechanisms underlying immune escape during disease progression and in response to therapeutic interventions. This review explores the key immune-evasive features of PCa, the contribution of the TME, and the immunotherapeutic strategies that have been clinically evaluated to improve outcomes in patients with advanced disease.
Permanent link
Publication status
published
External links
Editor
Book title
Journal / series
Volume
12 (11)
Pages / Article No.
1081 - 1105
Publisher
Elsevier
Event
Edition / version
Methods
Geographic location
Date collected
Date created
Subject
Organisational unit
09703 - Alimonti, Andrea / Alimonti, Andrea